Some days I feel so sick and tired of treatment that I consider not continuing. How can I handle these feelings?

 

Ask a Question

Q: Some days I feel so sick and tired of treatment that I consider not continuing. How can I handle these feelings? 

A: Your feelings are understandable. Cancer treatment can be highly stressful, physically and emotionally. As a little gift to yourself, create a soothing environment in a room at home so you’ll have a peaceful spot to return to after your medical appointments or treatment sessions. This can be done simply by re-arranging furniture, putting a small CD player near the chair or sofa where you’ll relax, and setting favorite objects or photos nearby.

It can also help to talk with others who are going through, have experienced, or understand what you’re feeling. Ask a social worker, nurse, or other member of your health care team to connect you with a patient support group or counselor who specializes in helping people with cancer.
--Bernice Crook, RN, OCN

Persistent feelings of sadness can lead to depression. These suggestions can help you take control.

Latest Cancer News
Avastin® Linked with Increased Risk of Blood Clots

November 20, 2008 — According to a combined analysis of previously published studies, cancer patients who use Avastin® (bevacizumab) may have an increased risk of venous thromboembolism (a blood clot in a vein). These results were published in the Journal of the American Medical Association.

Addition of Avastin® to Paraplatin®, Taxol®, and Erbitux® Promising for Advanced NSCLC

November 20, 2008 — Researchers affiliated with the Southwest Oncology Group have reported that the four-drug combination of chemotherapy agents Paraplatin® (carboplatin) and Taxol® (paclitaxel) plus targeted therapies Avastin® (bevacizumab) and Erbitux® (cetuximab) is safe and may improve survival in patients with advanced non–small cell lung cancer (NSCLC). The details of this study were presented at the 2008 Chicago Multidisciplinary Symposium in Thoracic Oncology November 13-15.

Avastin® Increases Risk of Venous Thromboembolism

November 20, 2008 — Researchers from Stony Brook University have reported that the use of Avastin® (bevacizumab) increases the risk of thromboembolism. The details of this review were published in the November 19, 2008 issue of the Journal of the American Medical Association.

Select news items provided by Reuters Health